Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
How CCTA could make ICA a thing of the past | Positron makes a move | New LAAO guidelines: 6 key takeaways
Monday, August 25, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Cardiac Imaging

CCTA could make invasive angiography a thing of the past

John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 

READ MORE >
Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.
Share on Twitter Share on Facebook Share on Linkedin

CCTA could make invasive angiography a thing of the past

Share on Twitter Share on Facebook Share on Linkedin
Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.
John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 
READ MORE >

Nuclear imaging company Positron moves to New York for ‘exciting new chapter’

Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.

READ MORE >
Positron NeuSight PET-CT 64 slice scanner
Share on Twitter Share on Facebook Share on Linkedin

Nuclear imaging company Positron moves to New York for ‘exciting new chapter’

Share on Twitter Share on Facebook Share on Linkedin
Positron NeuSight PET-CT 64 slice scanner
Positron made the move to help its case when it files an official Form 10 registration statement with the SEC.
READ MORE >

CCTA outperforms TEE after LAAO, new meta-analysis confirms

Researchers reviewed data from more than 1,300 patients who underwent both CCTA and TEE after undergoing LAAO. The two modalities were comparable in many ways, but cardiac CT was linked to a few key benefits.

READ MORE >
A CTA scan being performed at Beaumont Hospital in Michigan by cardiac CT expert Kavitha M Chinnaiyan, MD. CCTA has largely been used at academic medical centers for the past decade, but it is now expanding in 2022 to community hospitals and clinics thanks to a Class 1A recommendation in the 2021 chest pain guidelines. #CCTA #CTA #Beaumont
Share on Twitter Share on Facebook Share on Linkedin

CCTA outperforms TEE after LAAO, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
A CTA scan being performed at Beaumont Hospital in Michigan by cardiac CT expert Kavitha M Chinnaiyan, MD. CCTA has largely been used at academic medical centers for the past decade, but it is now expanding in 2022 to community hospitals and clinics thanks to a Class 1A recommendation in the 2021 chest pain guidelines. #CCTA #CTA #Beaumont
Researchers reviewed data from more than 1,300 patients who underwent both CCTA and TEE after undergoing LAAO. The two modalities were comparable in many ways, but cardiac CT was linked to a few key benefits.
READ MORE >

Shine working toward U.S. production of Mo-99 for SPECT nuclear imaging

Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.

READ MORE >
 Greg Piefer, PhD, CEO and founder of Shine, explains the timeline to restart U.S. production of molybdenum-99 (Mo-99) for nuclear imaging.
Share on Twitter Share on Facebook Share on Linkedin

Shine working toward U.S. production of Mo-99 for SPECT nuclear imaging

Share on Twitter Share on Facebook Share on Linkedin
 Greg Piefer, PhD, CEO and founder of Shine, explains the timeline to restart U.S. production of molybdenum-99 (Mo-99) for nuclear imaging.
Greg Piefer, PhD, chief executive and founder of Shine, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first sustained U.S. commercial supplier of molybdenum-99 in decades.
READ MORE >

New LAAO guidelines: 6 key takeaways for interventional cardiologists and electrophysiologists

SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

New LAAO guidelines: 6 key takeaways for interventional cardiologists and electrophysiologists

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.
READ MORE >

AI company raises $55M with help from leading health systems

Ultromics plans to use the new funds to help expand its presence throughout the United States. In addition, the company is focused on developing additional AI-enabled software offerings.

READ MORE >
artificial intelligence heart AI
Share on Twitter Share on Facebook Share on Linkedin

AI company raises $55M with help from leading health systems

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence heart AI
Ultromics plans to use the new funds to help expand its presence throughout the United States. In addition, the company is focused on developing additional AI-enabled software offerings.
READ MORE >

Pericarditis: New guidance takes on the diagnosis and management of a challenging heart condition

Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care. 

READ MORE >
Pericardial Effusion Sizing Evaluation by Echocardiography. Representative (A) small, (B) moderate, and (C) large PEffs (∗). Representative (D) simple PEff with fibrin strands, (E) exudative PEff, and (F) malignant PEff (∗) caused by pericardial mesothelioma. Adapted with permission from Klein et al. Images and caption courtesy of the American College of Cardiology and JACC.pericarditis cardiac imaging
Share on Twitter Share on Facebook Share on Linkedin

Pericarditis: New guidance takes on the diagnosis and management of a challenging heart condition

Share on Twitter Share on Facebook Share on Linkedin
Pericardial Effusion Sizing Evaluation by Echocardiography. Representative (A) small, (B) moderate, and (C) large PEffs (∗). Representative (D) simple PEff with fibrin strands, (E) exudative PEff, and (F) malignant PEff (∗) caused by pericardial mesothelioma. Adapted with permission from Klein et al. Images and caption courtesy of the American College of Cardiology and JACC.pericarditis cardiac imaging
Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup